Vibe Bioscience Ltd (TSE:VIBE)
:VIBE
Want to see TSE:VIBE full AI Analyst Report?
VIBE Stock Chart & Stats
C$0.06
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.06
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.15
Previous CloseN/A
Volume81.00K
Average Volume (3M)6.19K
Market Cap
C$539.85K
Enterprise ValueC$2.10M
Total Cash (Recent Filing)C$753.51K
Total Debt (Recent Filing)C$2.46M
Price to Earnings (P/E)―
Beta3.43
Next Earnings
May 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding10,796,989
10 Day Avg. Volume10,465
30 Day Avg. Volume6,194
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.06
Price to Sales (P/S)0.02
P/FCF Ratio25.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundA 10.1% revenue rebound in 2025 signals recovering market demand and better top-line momentum versus prior down years. Sustained revenue growth supports scale economics, funds R&D or commercialization, and reduces dependence on external capital if maintained over multiple quarters.
Operating Profitability ProgressPositive EBIT and EBITDA in 2025 indicate the core business model can generate operating earnings when volumes or cost controls align. Durable operating profitability reduces structural cash burn, demonstrates margin potential, and is a prerequisite for sustainable net profitability over a multi-quarter horizon.
Emerging Cash GenerationPositive operating and free cash flow across 2024–2025 shows the company can convert some sales into cash, improving near-term funding flexibility. If cash generation persists, it lowers refinancing needs, supports ongoing R&D or commercialization, and strengthens operational resilience.
Bears Say
Negative Shareholders' EquityNegative shareholders' equity reflects accumulated losses and a depleted capital base. This materially weakens financial flexibility, increases refinancing and dilution risk, constrains borrowing capacity, and makes the company more reliant on external capital to fund growth or cover setbacks.
Ongoing Net LossesA roughly -14% net margin in 2025 shows that below-the-line costs still outpace operating gains. Persistent net losses hinder retained earnings rebuild, create continued dependency on financing to fund operations, and mean long-term shareholder value depends on sustained margin improvement.
Fragile Cash Flow DurabilitySharp free cash flow decline in 2025 and prior inconsistent cash performance point to fragile cash generation. Without durable, growing FCF, the firm remains exposed to funding shortfalls, may need frequent external capital, and faces risk in sustaining R&D, commercialization, or unexpected expenses.
Vibe Bioscience Ltd News
VIBE FAQ
What was Vibe Bioscience Ltd’s price range in the past 12 months?
Vibe Bioscience Ltd lowest stock price was C$0.04 and its highest was C$0.15 in the past 12 months.
What is Vibe Bioscience Ltd’s market cap?
Vibe Bioscience Ltd’s market cap is C$539.85K.
When is Vibe Bioscience Ltd’s upcoming earnings report date?
Vibe Bioscience Ltd’s upcoming earnings report date is May 28, 2026 which is in 23 days.
How were Vibe Bioscience Ltd’s earnings last quarter?
Currently, no data Available
Is Vibe Bioscience Ltd overvalued?
According to Wall Street analysts Vibe Bioscience Ltd’s price is currently Overvalued.
Does Vibe Bioscience Ltd pay dividends?
Vibe Bioscience Ltd does not currently pay dividends.
What is Vibe Bioscience Ltd’s EPS estimate?
Vibe Bioscience Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vibe Bioscience Ltd have?
Vibe Bioscience Ltd has 10,796,989 shares outstanding.
What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vibe Bioscience Ltd?
Currently, no hedge funds are holding shares in TSE:VIBE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vibe Bioscience Ltd
Vibe Growth Corporation engages in the cultivation, production, retail, and distribution of cannabis for recreation and medicinal. The company operates five dispensaries, one distribution, and two cultivation operations, as well as sells its products through its e-commerce platform under the Vibe By California brand. It also involved in the indoor cultivation; commercial distribution and transportation; e-commerce and home delivery; and manufacturing of marijuana products. The company was formerly known as Vibe Bioscience Ltd. and changed its name to Vibe Growth Corporation in October 2020. Vibe Growth Corporation was incorporated in 2020 and is headquartered in Sacramento, California.
Technical Analysis
Molecule Holdings
―
Global Hemp
―
―
Asia Green Biotechnology Corp.
―
Xebra Brands Ltd.
―
Options Prices
Currently, No data available
---